Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

Jerome Galon; Fabienne Hermitte; Bernhard Mlecnik; Florence Marliot; Carlo Bruno Bifulco; Alessandro Lugli; Iris D. Nagtegaal; Arndt Hartmann; Marc Van Den Eynde; Michael H. A. Roehrl; Pamela S Ohashi; Eva Zavadova; Toshihiko Torigoe; Prabhudas S. Patel; Yili Wang; Yutaka Kawakami; Francesco Marincola; Paolo Antonio Ascierto; Bernard A. Fox; Franck Pages

doi:10.1200/JCO.2019.37.4_SUPPL.487

Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

Jerome Galon
, Fabienne Hermitte
, Bernhard Mlecnik
, Florence Marliot
, Carlo Bruno Bifulco
, Alessandro Lugli
, Iris D. Nagtegaal
, Arndt Hartmann
, Marc Van Den Eynde
, Michael H. A. Roehrl
, Pamela S Ohashi
, Eva Zavadova
, Toshihiko Torigoe
, Prabhudas S. Patel
, Yili Wang
, Yutaka Kawakami
, Francesco Marincola
, Paolo Antonio Ascierto
, Bernard A. Fox
, Franck Pages

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	37
DOIs	https://doi.org/10.1200/JCO.2019.37.4_SUPPL.487
State	Published - Jan 29 2019

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1200/JCO.2019.37.4_SUPPL.487License: Unspecified

Cite this

Galon, J., Hermitte, F., Mlecnik, B., Marliot, F., Bifulco, C. B., Lugli, A., Nagtegaal, I. D., Hartmann, A., Van Den Eynde, M., Roehrl, M. H. A., Ohashi, P. S., Zavadova, E., Torigoe, T., Patel, P. S., Wang, Y., Kawakami, Y., Marincola, F., Ascierto, P. A., Fox, B. A., & Pages, F. (2019). Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided. Journal of Clinical Oncology, 37. https://doi.org/10.1200/JCO.2019.37.4_SUPPL.487

@article{9b513c7e439c479f9be005eb34bf5a92,

title = "Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.",

author = "Jerome Galon and Fabienne Hermitte and Bernhard Mlecnik and Florence Marliot and Bifulco, \{Carlo Bruno\} and Alessandro Lugli and Nagtegaal, \{Iris D.\} and Arndt Hartmann and \{Van Den Eynde\}, Marc and Roehrl, \{Michael H. A.\} and Ohashi, \{Pamela S\} and Eva Zavadova and Toshihiko Torigoe and Patel, \{Prabhudas S.\} and Yili Wang and Yutaka Kawakami and Francesco Marincola and Ascierto, \{Paolo Antonio\} and Fox, \{Bernard A.\} and Franck Pages",

note = "487 Background: Immunoscore Colon is an IVD test predicting the risk of relapse in early-stage colon cancer (CC) patients, by measuring the host immune response at the tumor site. It is a risk-assessment tool providing independent and superior prognostic value than the usual tumor risk parameters and is intended to be used as an adjunct to the TNM classification.",

year = "2019",

month = jan,

day = "29",

doi = "10.1200/JCO.2019.37.4\_SUPPL.487",

language = "American English",

volume = "37",

journal = "Journal of Clinical Oncology",

}

Galon, J, Hermitte, F, Mlecnik, B, Marliot, F, Bifulco, CB, Lugli, A, Nagtegaal, ID, Hartmann, A, Van Den Eynde, M, Roehrl, MHA, Ohashi, PS, Zavadova, E, Torigoe, T, Patel, PS, Wang, Y, Kawakami, Y, Marincola, F, Ascierto, PA, Fox, BA & Pages, F 2019, 'Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.', Journal of Clinical Oncology, vol. 37. https://doi.org/10.1200/JCO.2019.37.4_SUPPL.487

TY - JOUR

T1 - Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

AU - Galon, Jerome

AU - Hermitte, Fabienne

AU - Mlecnik, Bernhard

AU - Marliot, Florence

AU - Bifulco, Carlo Bruno

AU - Lugli, Alessandro

AU - Nagtegaal, Iris D.

AU - Hartmann, Arndt

AU - Van Den Eynde, Marc

AU - Roehrl, Michael H. A.

AU - Ohashi, Pamela S

AU - Zavadova, Eva

AU - Torigoe, Toshihiko

AU - Patel, Prabhudas S.

AU - Wang, Yili

AU - Kawakami, Yutaka

AU - Marincola, Francesco

AU - Ascierto, Paolo Antonio

AU - Fox, Bernard A.

AU - Pages, Franck

N1 - 487 Background: Immunoscore Colon is an IVD test predicting the risk of relapse in early-stage colon cancer (CC) patients, by measuring the host immune response at the tumor site. It is a risk-assessment tool providing independent and superior prognostic value than the usual tumor risk parameters and is intended to be used as an adjunct to the TNM classification.

PY - 2019/1/29

Y1 - 2019/1/29

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.4_suppl.487

U2 - 10.1200/JCO.2019.37.4_SUPPL.487

DO - 10.1200/JCO.2019.37.4_SUPPL.487

M3 - Article

VL - 37

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

Disciplines

Access to Document

Other files and links

Cite this